Skip to content

The use of hormone therapy (HT) by menopausal women declined by about two-thirds after the publication of the Women’s Health Initiative Study in 2002. In order to evaluate how the WHI influenced women’s knowledge, attitudes and perceptions towards HT use, as well as to find out their specific concerns and sources of information, Tao and colleagues [1] reviewed 11 qualitative studies ([i]n[/i] = 566) and 27 quantitative studies ([i]n[/i] = 39,251). Using meta-synthesis methods, they reviewed the qualitative studies and surveys and performed content analysis on the study reports. They pooled the quantitative studies using a random-effects meta-analysis. By applying a meta-synthesis approach, they feel that these findings are broadly applicable across large groups of patients. They report that women are positive about the use of menopausal hormone therapy (MHT) for symptom control, prevention of osteoporosis and improved quality of life. Concerns exist about potential harmful effects, particularly cancer risks. Sources of information include health providers, media, and social contacts. Media, as a source of information, is often valued as equivalent to health providers. Women in the developing world have less access to alternative sources of information than women in industrialized countries, a fact that concerns the authors.

Author(s)

  • Regula Bürki
    Hirslanden Hospital Group, Berne, Switzerland

Citations

  1. Tao M, Teng Y, Shao H, Wu P, Mills EJ. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 2011;6:e24661.
    http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0024661
  2. Power ML, Anderson BL, Schulkin J. Attitudes of obstetrician-gynecologists toward the evidence from the Womens Health Initiative hormone therapy trials remain generally skeptical. Menopause 2009;16:5008.
    http://www.ncbi.nlm.nih.gov/pubmed/19169162
  3. Fugh-Berman A, McDonald CP, Bell AM, Bethards CE, Scialli RA. Promotional tone in reviews of menopausal hormone therapy after the Womens Health Initiative: an analysis of published articles. PLoS Med 2011;8:e100425.
    http://www.ncbi.nlm.nih.gov/pubmed/21423581
  4. Sturdee DW, Pines A, on behalf of the International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:30220. (Adopted by the Asia Pacific Menopause Federation 2011).
    http://www.ncbi.nlm.nih.gov/pubmed/21563996
  5. Gompel A, Rozenberg S, Barlow DH; EMAS board members. The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 2008;61:227-32.
    http://www.ncbi.nlm.nih.gov/pubmed/19028033
  6. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
    http://www.menopause.org/PSht10.pdf
  7. Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab 2011;96:255-64.
    http://www.ncbi.nlm.nih.gov/pubmed/21296989
  8. Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization. Menopause 2011;18:1172-7.
    http://www.ncbi.nlm.nih.gov/pubmed/21775911
  9. Gambacciani M. HRT misuse and the osteoporosis epidemic. Climacteric 2011 December 1. Epub ahead of print.
    http://www.ncbi.nlm.nih.gov/pubmed/22132704

Having trouble opening PDFs? Download Adobe Reader here.

International Menopause Society

Install International Menopause Society - DEV

Install this application on your home screen for quick and easy access when you’re on the go.

Just tap then “Add to Home Screen”

DBS Check Online Certified